No takes yet. Share an insight, caveat, or question.
Retrospective analysis shows HFRT with concomitant boost achieves high local control in early-stage breast cancer, suggesting it as a beneficial treatment option.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: